retatrutide safety retatrutide clinical trial Efficacy and of retatrutide, a GIP, GLP-1, and glucagon receptor agonist, in people with type 2 diabetes and inadequate glycaemic control with diet and exercise (TRANSCEND-T2D-1): a double-blind, randomised, phase 3 Retatrutide for the treatment of

The Adapt Lab is led by Dr

Virta Health helps people improve blood sugar control with medical support and one-on-one virtual coaching, which can reduce diabetes-related dry mouth and other symptoms

Competition, creativity Danone takes cues from pharma marketing as GLP-1 changes appetites GLP-1 Weight Loss Drugs: 4 Strategic Responses for Food Brand Why GLP-1 trials demand tailored patient engagement How to Generate Meaningful Engagement in GLP-1 Programs 5 Key Lessons Learned in U.S

: ,

Future studies with larger populations and long-term follow-ups are necessary to gain a clearer understanding of the chronic effects of these medications and their safety profiles in clinical practice